Helen Chow

898 total citations
23 papers, 645 citations indexed

About

Helen Chow is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Helen Chow has authored 23 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Helen Chow's work include Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Genetic factors in colorectal cancer (3 papers). Helen Chow is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Genetic factors in colorectal cancer (3 papers). Helen Chow collaborates with scholars based in Canada, United States and Australia. Helen Chow's co-authors include Kevin Klucher, Leonore Reiser, Robert L. Fischer, Robert L. Fischer, Stanley A. Yap, P. Ghosh, Laurel Beckett, Ralph Devere White, Chong-xian Pan and Christopher P. Evans and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Plant Cell.

In The Last Decade

Helen Chow

21 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Chow Canada	8	473	462	58	51	41	23	645
Yuanyuan Xiong China	12	302 0.6×	216 0.5×	44 0.8×	47 0.9×	73 1.8×	34	470
Jieyang Lu China	13	469 1.0×	259 0.6×	81 1.4×	48 0.9×	190 4.6×	25	606
Tomomi Yamada Japan	8	219 0.5×	148 0.3×	47 0.8×	19 0.4×	22 0.5×	13	342
Fengtong Li China	13	168 0.4×	207 0.4×	86 1.5×	77 1.5×	35 0.9×	28	440
Anna Nowicka Poland	15	309 0.7×	284 0.6×	86 1.5×	53 1.0×	107 2.6×	34	532
Benjamin C. Carter United States	10	487 1.0×	152 0.3×	25 0.4×	40 0.8×	73 1.8×	11	591
Liyu Huang China	13	272 0.6×	56 0.1×	27 0.5×	57 1.1×	70 1.7×	22	383
Shalu Mittal United States	5	268 0.6×	172 0.4×	16 0.3×	82 1.6×	54 1.3×	7	482
Qiao-Juan Huang China	11	421 0.9×	183 0.4×	22 0.4×	43 0.8×	189 4.6×	17	588
Zeyu Yang China	12	281 0.6×	161 0.3×	69 1.2×	79 1.5×	103 2.5×	23	534

Countries citing papers authored by Helen Chow

Since Specialization

Citations

This map shows the geographic impact of Helen Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Chow more than expected).

Fields of papers citing papers by Helen Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Chow. The network helps show where Helen Chow may publish in the future.

Co-authorship network of co-authors of Helen Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Chow. A scholar is included among the top collaborators of Helen Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Chow. Helen Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mintz, Mark, Victor Badner, Jonathan Diaz, et al.. (2025). Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target. Psychopharmacology Bulletin. 52(3). 20–30.

Marhon, Sajid A., Farnoosh Abbas‐Aghababazadeh, David Chen, et al.. (2025). Abstract 2060: Independent validation of endogenous retrotransposable elements as predictive biomarkers of immune checkpoint blockade response. Cancer Research. 85(8_Supplement_1). 2060–2060.

Xiong, Ge, Richard Young, Helen Chow, et al.. (2023). Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review. Frontiers in Oncology. 13. 1199195–1199195. 4 indexed citations

Elliott, Mitchell J., Zachary Veitch, Philippe L. Bédard, et al.. (2023). Abstract P6-01-16: Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort. Cancer Research. 83(5_Supplement). P6–1. 2 indexed citations

Araújo, Daniel Vilarim, Ao Wang, Dax Torti, et al.. (2020). Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy. JNCI Cancer Spectrum. 5(3). 16 indexed citations

Spence, Tara, Natalie Stickle, Celeste Yu, et al.. (2019). Inter-Laboratory Proficiency Testing Scheme for Tumour Next-Generation Sequencing in Ontario: A Pilot Study. Current Oncology. 26(6). 717–732. 2 indexed citations

Tan, Tira J., Lisa Wang, Helen Chow, et al.. (2019). Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era. The Oncologist. 24(7). e518–e525. 1 indexed citations

Tan, Tira J., Marcus O. Butler, Aaron R. Hansen, et al.. (2019). Feasibility study of microbial ecosystem therapeutics (MET-4) to evaluate effects of fecal microbiome in patients on immunotherapy (MET4-IO).. Journal of Clinical Oncology. 37(15_suppl). TPS2664–TPS2664. 4 indexed citations

Jonas, Brian A., Peter Curtin, Gary J. Schiller, et al.. (2018). A Phase 1 Trial of Ibrutinib (IBR) and Azacitidine (AZA) for the Treatment of Higher-Risk Myelodysplastic Syndromes (HR-MDS): Updated Results of University of California Hematologic Malignancies Consortium (UCHMC) Study 1503. Blood. 132(Supplement 1). 3088–3088. 4 indexed citations

10.

Stjepanovic, Neda, Michelle Wilson, Hal K. Berman, et al.. (2017). Abstract P3-09-05: Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene. Cancer Research. 77(4_Supplement). P3–9. 2 indexed citations

11.

Clouthier, Derek, Cindy Yang, Scott Lien, et al.. (2017). A technical feasibility report on correlative studies from the investigator-initiated phase II study of pembrolizumab (Pembro) immunological response evaluation (INSPIRE).. Journal of Clinical Oncology. 35(15_suppl). 11607–11607. 1 indexed citations

12.

Colombo, Ilaria, Scott Lien, Cindy Yang, et al.. (2017). Immunologic and genomic characterization of high grade serous ovarian cancer (HGSOC) in patients (pts) treated with pembrolizumab (Pembro) in the phase II INSPIRE trial.. Journal of Clinical Oncology. 35(15_suppl). 5581–5581. 2 indexed citations

13.

Fallah‐Rad, Nazanin, Philippe L. Bédard, Lillian L. Siu, et al.. (2016). Association of isocitrate dehydorgenase-1 (IDH-1) mutations with elevated oncometabolite 2-hydroxyglutarate (2HG) in advanced colorectal cancer.. Journal of Clinical Oncology. 34(4_suppl). 627–627. 7 indexed citations

14.

Chow, Helen, Martin J. Edelman, Suresh S. Ramalingam, et al.. (2015). Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(10). 1421–1429. 3 indexed citations

15.

Pan, Chong-xian, Helen Chow, P. Ghosh, et al.. (2014). Everolimus plus bicalutamide in men with castration-resistant prostate cancer (CRPC): Final results of a phase II trial.. Journal of Clinical Oncology. 32(15_suppl). 5028–5028. 1 indexed citations

16.

Spreafico, Anna, Amit M. Oza, Blaise Clarke, et al.. (2014). Genotype matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 32(15_suppl). 5506–5506. 4 indexed citations

17.

Ji, Ping, et al.. (2002). Prevention of chronic rejection by pravastatin in a rat kidney transplant model.. Transplantation. 74(6). 821–827. 20 indexed citations

18.

Klucher, Kevin, Helen Chow, Leonore Reiser, & Robert L. Fischer. (1996). The AINTEGUMENTA gene of Arabidopsis required for ovule and female gametophyte development is related to the floral homeotic gene APETALA2.. The Plant Cell. 8(2). 137–153. 421 indexed citations

19.

Klucher, Kevin, Helen Chow, Leonore Reiser, & Robert L. Fischer. (1996). The AINTEGUMENTA Gene of Arabidopsis Required for Ovule and Female Gametophyte Development Is Related to the Floral Homeotic Gene APETALA2. The Plant Cell. 8(2). 137–137. 59 indexed citations

20.

Chow, Helen, R. Lane, & Isaac I. Rosen. (1990). Uncertainty in dose estimation for gynecological implants. International Journal of Radiation Oncology*Biology*Physics. 19(6). 1555–1559. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact